| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ins 316 | p2y purinoceptor 11 | NA | Discontinued target | TTD | Malignant neoplasm of lung[MeSHID:D008175] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | discontinued in phase 3 | unknown |
| ins 316 | p2y purinoceptor 2 | small molecule | Clinical trial target | TTD , drugbank | Malignant neoplasm of lung[MeSHID:D008175] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigational,discontinued in phase 3 | unknown |
| ins 316 | p2y purinoceptor 4 | NA | Discontinued target | TTD | Malignant neoplasm of lung[MeSHID:D008175] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | discontinued in phase 3 | unknown |
| ins 316 | p2y purinoceptor 6 | NA | Clinical trial target | TTD | Malignant neoplasm of lung[MeSHID:D008175] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | discontinued in phase 3 | unknown |
| click here to return to the previous page | ||||||||